Acro Biomedical (ACBM) Long-Term Deferred Tax (2018 - 2019)
Acro Biomedical (ACBM) recorded quarterly Long-Term Deferred Tax of $9871.0 in Q2 2019, down 84.83% quarter-over-quarter from $65065.0 in Q1 2019.
Acro Biomedical (ACBM) Long-Term Deferred Tax (2018 - 2019) Analysis & Trends
Acro Biomedical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $9871.0 for Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 9,871.00 |
| Mar 31, 2019 | 65,065.00 |
| Dec 31, 2018 | 19,941.00 |